Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder Neoplasms | 49 | 2024 | 2223 | 8.820 |
Why?
|
Cystectomy | 23 | 2024 | 634 | 6.490 |
Why?
|
Carcinoma, Transitional Cell | 5 | 2022 | 782 | 1.650 |
Why?
|
Prostatectomy | 8 | 2023 | 1825 | 1.520 |
Why?
|
Urologic Neoplasms | 6 | 2021 | 314 | 1.500 |
Why?
|
Urology | 5 | 2023 | 400 | 1.320 |
Why?
|
Urinary Bladder | 7 | 2023 | 1152 | 1.080 |
Why?
|
Penile Neoplasms | 5 | 2023 | 161 | 1.060 |
Why?
|
Postoperative Complications | 17 | 2023 | 15637 | 1.030 |
Why?
|
Health Care Costs | 5 | 2020 | 3239 | 0.960 |
Why?
|
Kidney Neoplasms | 7 | 2022 | 4251 | 0.870 |
Why?
|
Urologic Surgical Procedures | 5 | 2019 | 298 | 0.860 |
Why?
|
Ureteral Neoplasms | 2 | 2021 | 107 | 0.730 |
Why?
|
Muscle Neoplasms | 2 | 2019 | 130 | 0.730 |
Why?
|
Nephrectomy | 5 | 2022 | 938 | 0.690 |
Why?
|
Prostatic Neoplasms | 11 | 2023 | 11101 | 0.680 |
Why?
|
Medical Records | 2 | 2016 | 1409 | 0.670 |
Why?
|
Smoking Cessation | 4 | 2023 | 2056 | 0.660 |
Why?
|
Neoplasm Invasiveness | 12 | 2024 | 3590 | 0.650 |
Why?
|
Guideline Adherence | 4 | 2021 | 2220 | 0.640 |
Why?
|
Kidney Pelvis | 1 | 2019 | 186 | 0.620 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2021 | 617 | 0.570 |
Why?
|
Information Seeking Behavior | 1 | 2018 | 116 | 0.570 |
Why?
|
Cost of Illness | 2 | 2017 | 1936 | 0.530 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2016 | 78 | 0.530 |
Why?
|
Blood Transfusion | 2 | 2020 | 1303 | 0.520 |
Why?
|
Patient-Centered Care | 5 | 2019 | 1427 | 0.510 |
Why?
|
Antibiotic Prophylaxis | 3 | 2017 | 637 | 0.500 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2219 | 0.500 |
Why?
|
Neoplasm Staging | 13 | 2022 | 11119 | 0.480 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1852 | 0.450 |
Why?
|
Aftercare | 1 | 2020 | 913 | 0.440 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 934 | 0.440 |
Why?
|
Retrospective Studies | 36 | 2024 | 80675 | 0.430 |
Why?
|
Muscles | 4 | 2022 | 1568 | 0.430 |
Why?
|
Pathology, Surgical | 1 | 2014 | 151 | 0.420 |
Why?
|
Anemia | 1 | 2022 | 1504 | 0.410 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11733 | 0.410 |
Why?
|
Health Literacy | 2 | 2016 | 444 | 0.400 |
Why?
|
Patients | 1 | 2018 | 906 | 0.390 |
Why?
|
Medically Underserved Area | 1 | 2014 | 254 | 0.390 |
Why?
|
Humans | 85 | 2024 | 761222 | 0.360 |
Why?
|
Physician's Role | 1 | 2017 | 920 | 0.360 |
Why?
|
Carcinoma, Renal Cell | 2 | 2022 | 3163 | 0.360 |
Why?
|
Occupational Exposure | 1 | 2021 | 1814 | 0.360 |
Why?
|
Smoking | 6 | 2023 | 9055 | 0.360 |
Why?
|
Aged | 40 | 2024 | 169292 | 0.350 |
Why?
|
Reoperation | 2 | 2019 | 4303 | 0.340 |
Why?
|
Male | 58 | 2024 | 360703 | 0.340 |
Why?
|
Population Surveillance | 1 | 2020 | 2598 | 0.320 |
Why?
|
Venous Thromboembolism | 2 | 2019 | 1869 | 0.320 |
Why?
|
Androgen Antagonists | 1 | 2017 | 1408 | 0.310 |
Why?
|
Prostate-Specific Antigen | 1 | 2018 | 2465 | 0.310 |
Why?
|
Disease Management | 2 | 2019 | 2507 | 0.290 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2021 | 3512 | 0.290 |
Why?
|
Middle Aged | 39 | 2024 | 220858 | 0.280 |
Why?
|
Anti-Infective Agents | 1 | 2014 | 983 | 0.280 |
Why?
|
Physician-Patient Relations | 2 | 2017 | 3253 | 0.280 |
Why?
|
Databases, Factual | 8 | 2020 | 7965 | 0.270 |
Why?
|
BCG Vaccine | 4 | 2023 | 369 | 0.270 |
Why?
|
Biomedical Research | 2 | 2021 | 3434 | 0.270 |
Why?
|
Internet | 1 | 2018 | 3096 | 0.260 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2317 | 0.260 |
Why?
|
Hospital Costs | 3 | 2022 | 947 | 0.260 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2021 | 549 | 0.260 |
Why?
|
Cancer Care Facilities | 2 | 2020 | 422 | 0.240 |
Why?
|
Anticoagulants | 2 | 2023 | 4795 | 0.240 |
Why?
|
Risk Factors | 12 | 2021 | 74241 | 0.240 |
Why?
|
Patient Readmission | 3 | 2017 | 3265 | 0.240 |
Why?
|
Female | 41 | 2024 | 392552 | 0.240 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.240 |
Why?
|
Neoadjuvant Therapy | 4 | 2021 | 2827 | 0.230 |
Why?
|
Health Services Accessibility | 3 | 2019 | 5426 | 0.220 |
Why?
|
Vinblastine | 2 | 2021 | 488 | 0.210 |
Why?
|
Survival Rate | 8 | 2021 | 12728 | 0.210 |
Why?
|
Environmental Exposure | 1 | 2017 | 4479 | 0.200 |
Why?
|
Incidence | 7 | 2023 | 21366 | 0.200 |
Why?
|
Comorbidity | 5 | 2021 | 10516 | 0.190 |
Why?
|
Adjuvants, Immunologic | 3 | 2023 | 988 | 0.190 |
Why?
|
Communication | 2 | 2017 | 3872 | 0.180 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2020 | 13 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2023 | 4021 | 0.180 |
Why?
|
Ileus | 1 | 2020 | 66 | 0.170 |
Why?
|
Deoxycytidine | 2 | 2021 | 878 | 0.170 |
Why?
|
Length of Stay | 5 | 2021 | 6417 | 0.170 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7400 | 0.160 |
Why?
|
Survival Analysis | 4 | 2021 | 10088 | 0.160 |
Why?
|
Obesity | 2 | 2020 | 12940 | 0.160 |
Why?
|
Histological Techniques | 1 | 2019 | 193 | 0.150 |
Why?
|
Episode of Care | 1 | 2019 | 128 | 0.150 |
Why?
|
Germ Cells | 1 | 2022 | 632 | 0.150 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 492 | 0.150 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8519 | 0.150 |
Why?
|
Surgical Procedures, Operative | 2 | 2021 | 1923 | 0.150 |
Why?
|
Cisplatin | 2 | 2021 | 1652 | 0.150 |
Why?
|
Aged, 80 and over | 14 | 2024 | 58952 | 0.150 |
Why?
|
Biopsy | 3 | 2019 | 6781 | 0.150 |
Why?
|
Defoliants, Chemical | 1 | 2017 | 9 | 0.150 |
Why?
|
Age Factors | 6 | 2021 | 18384 | 0.150 |
Why?
|
Medical Oncology | 2 | 2021 | 2320 | 0.150 |
Why?
|
Doxorubicin | 2 | 2021 | 2224 | 0.150 |
Why?
|
Methotrexate | 2 | 2021 | 1718 | 0.150 |
Why?
|
United States | 15 | 2023 | 72341 | 0.140 |
Why?
|
Treatment Outcome | 13 | 2021 | 64681 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 2023 | 801 | 0.140 |
Why?
|
Washington | 2 | 2017 | 314 | 0.140 |
Why?
|
Vietnam Conflict | 1 | 2017 | 101 | 0.140 |
Why?
|
Hospital Charges | 1 | 2019 | 350 | 0.140 |
Why?
|
Prognosis | 6 | 2022 | 29688 | 0.140 |
Why?
|
Prostate | 2 | 2022 | 1772 | 0.140 |
Why?
|
Cystoscopy | 2 | 2014 | 131 | 0.140 |
Why?
|
Lymph Nodes | 2 | 2018 | 3461 | 0.130 |
Why?
|
Attitude of Health Personnel | 2 | 2023 | 3885 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 212 | 0.130 |
Why?
|
Risk Assessment | 5 | 2021 | 24022 | 0.130 |
Why?
|
Hospital Mortality | 3 | 2019 | 5295 | 0.130 |
Why?
|
Research Report | 1 | 2019 | 367 | 0.130 |
Why?
|
Lymphatic Metastasis | 3 | 2018 | 2913 | 0.130 |
Why?
|
SEER Program | 4 | 2023 | 1453 | 0.120 |
Why?
|
Carcinoma in Situ | 1 | 2020 | 791 | 0.120 |
Why?
|
Watchful Waiting | 1 | 2019 | 489 | 0.120 |
Why?
|
Hospitals | 2 | 2019 | 3881 | 0.120 |
Why?
|
Insurance, Health | 2 | 2019 | 2493 | 0.120 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12052 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6486 | 0.110 |
Why?
|
Registries | 3 | 2019 | 8246 | 0.110 |
Why?
|
Truth Disclosure | 1 | 2017 | 432 | 0.110 |
Why?
|
Patient Transfer | 2 | 2017 | 794 | 0.110 |
Why?
|
Transurethral Resection of Prostate | 1 | 2014 | 79 | 0.110 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5333 | 0.110 |
Why?
|
Lymph Node Excision | 4 | 2023 | 1270 | 0.110 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5493 | 0.110 |
Why?
|
Mortality | 3 | 2019 | 2896 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1155 | 0.100 |
Why?
|
Circumcision, Male | 1 | 2014 | 148 | 0.100 |
Why?
|
Radiotherapy | 1 | 2019 | 1500 | 0.100 |
Why?
|
Laparoscopy | 1 | 2023 | 2035 | 0.100 |
Why?
|
Quality of Health Care | 2 | 2019 | 4321 | 0.100 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.090 |
Why?
|
Regression Analysis | 1 | 2020 | 6345 | 0.090 |
Why?
|
Health Maintenance Organizations | 1 | 2014 | 658 | 0.090 |
Why?
|
Cystotomy | 1 | 2010 | 4 | 0.090 |
Why?
|
Workplace | 1 | 2017 | 864 | 0.090 |
Why?
|
Medicare | 3 | 2020 | 6774 | 0.090 |
Why?
|
Urinary Bladder Calculi | 1 | 2010 | 12 | 0.090 |
Why?
|
Tumor Burden | 1 | 2016 | 1892 | 0.090 |
Why?
|
Adult | 15 | 2024 | 221120 | 0.090 |
Why?
|
Neoplasm Metastasis | 2 | 2021 | 4909 | 0.090 |
Why?
|
Research | 1 | 2018 | 1976 | 0.080 |
Why?
|
Patient Preference | 1 | 2017 | 927 | 0.080 |
Why?
|
Rectal Neoplasms | 1 | 2018 | 1156 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9278 | 0.080 |
Why?
|
Cohort Studies | 3 | 2023 | 41496 | 0.080 |
Why?
|
Genomics | 2 | 2022 | 5829 | 0.080 |
Why?
|
Lithotripsy | 1 | 2010 | 140 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1201 | 0.080 |
Why?
|
Logistic Models | 4 | 2019 | 13249 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14675 | 0.080 |
Why?
|
Hypocalcemia | 1 | 2010 | 200 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12474 | 0.080 |
Why?
|
Military Personnel | 1 | 2017 | 1246 | 0.070 |
Why?
|
Environmental Pollutants | 1 | 2017 | 1276 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1910 | 0.070 |
Why?
|
Delirium | 1 | 2018 | 1668 | 0.070 |
Why?
|
Equipment Design | 1 | 2014 | 3510 | 0.060 |
Why?
|
Pilot Projects | 2 | 2016 | 8642 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2022 | 11512 | 0.060 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2024 | 37 | 0.060 |
Why?
|
Thyroidectomy | 1 | 2010 | 908 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5809 | 0.060 |
Why?
|
Administration, Intravesical | 1 | 2023 | 91 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 22142 | 0.060 |
Why?
|
Veterans | 1 | 2017 | 2656 | 0.050 |
Why?
|
Parathyroid Hormone | 1 | 2010 | 1803 | 0.050 |
Why?
|
Health Personnel | 1 | 2017 | 3337 | 0.050 |
Why?
|
Retroperitoneal Space | 1 | 2023 | 170 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10707 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7804 | 0.050 |
Why?
|
Censuses | 1 | 2023 | 198 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 39957 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4584 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6341 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9652 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3608 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17897 | 0.040 |
Why?
|
Perioperative Period | 1 | 2021 | 252 | 0.040 |
Why?
|
Radiology Information Systems | 1 | 2024 | 529 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39127 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2023 | 463 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2013 | 5301 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7407 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13386 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 59222 | 0.040 |
Why?
|
Calibration | 1 | 2020 | 819 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26072 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2021 | 927 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1624 | 0.030 |
Why?
|
Quality of Life | 2 | 2018 | 13367 | 0.030 |
Why?
|
Calcium | 1 | 2010 | 5719 | 0.030 |
Why?
|
Penis | 1 | 2017 | 212 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36415 | 0.030 |
Why?
|
Adolescent | 3 | 2019 | 88300 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1636 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10553 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 385 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 999 | 0.030 |
Why?
|
DNA Repair | 1 | 2024 | 2041 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 2020 | 509 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2478 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 2020 | 698 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15521 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2643 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15308 | 0.030 |
Why?
|
Professional Role | 1 | 2017 | 313 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2019 | 834 | 0.030 |
Why?
|
Personality | 1 | 2017 | 553 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 708 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2017 | 545 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3584 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2017 | 1784 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 54437 | 0.020 |
Why?
|
Societies, Medical | 1 | 2023 | 3923 | 0.020 |
Why?
|
Social Behavior | 1 | 2017 | 1136 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2017 | 1506 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2981 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1437 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 14025 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4642 | 0.020 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2010 | 173 | 0.020 |
Why?
|
Health Expenditures | 1 | 2020 | 2362 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7033 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9616 | 0.020 |
Why?
|
Social Support | 1 | 2017 | 2175 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2254 | 0.020 |
Why?
|
Medicaid | 1 | 2019 | 2813 | 0.020 |
Why?
|
California | 1 | 2010 | 1431 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3201 | 0.020 |
Why?
|
Catheterization | 1 | 2010 | 1428 | 0.010 |
Why?
|
Inpatients | 1 | 2015 | 2545 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3354 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4077 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8663 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20118 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3441 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3251 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5842 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29893 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10218 | 0.010 |
Why?
|
Infant | 1 | 2010 | 36170 | 0.000 |
Why?
|
Child, Preschool | 1 | 2010 | 42225 | 0.000 |
Why?
|
Concepts
(250)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(64)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_